# Healthleap

> Clinical AI platform that screens inpatient records for conditions hospitals may miss.

## Why it is interesting

Healthleap links AI screening to both patient outcomes and hospital reimbursement, creating measurable ROI but raising high clinical-validation and workflow-integration requirements.

## Profile

- **Latest funding:** Seed and Series A (aggregate) — $38 million (October 7, 2026)
- **Latest known valuation:** Not publicly disclosed
- **Total disclosed equity funding:** $38M
- **Stage:** series-a
- **Status:** private
- **Industries:** ai-ml, healthtech
- **Coverage:** full
- **Last updated:** 2026-10-09T02:03:00.000Z
- **Latest funding investors:** Sequoia Capital, First Round Capital, Hummingbird Ventures

## Key facts

- Screens adult inpatients daily at more than 20 hospitals, according to the company.
- Named customers include Penn Medicine, Houston Methodist, Cedars-Sinai and Emory Healthcare.

## Funding history

- Seed and Series A (aggregate) · $38 million · October 7, 2026
  Source: https://healthleap.ai/series-a

## Investors in our directory

- https://venturecapitaltracker.com/fund/sequoia
- https://venturecapitaltracker.com/fund/first-round-capital-nyc
- https://venturecapitaltracker.com/fund/hummingbird-ventures

## Related articles

- https://venturecapitaltracker.com/2026-healthleap-38m-seed-series-a-clinical-ai

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)
**Last updated:** October 9, 2026

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

---
Source: https://venturecapitaltracker.com/startup/healthleap